BridgeMD
New treatment option for Child Behavior
Official title Neuromuscular Mechanisms of Specific Trunk Interventions in Children With CP
ClinicalTrials.gov ID: NCT05805410
What this study is testing
- What it's testing
- Determine the effect of repeated pelvis perturbation training on trunk posture and locomotor function in children with CP.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 12
You may be able to join if
- Children with a diagnosis of bilateral spastic CP attributed to complications of prematurity, intracranial hemorrhage and periventricular leukmalacia...
- Children aged 4 to 12 years old without Botulinum toxin treatment within 6 months, and without surgeries (such as selective dorsal rhizotomy) within...
- people will be able to remain seated without help for ≥10s.
- GMFCS levels will be I to IV.
- Children must be able to signal pain, fear or discomfort reliably.
You likely can't join if
- severe lower extremity contractures, fractures, osseous instabilities, osteoporosis.
- severe disproportional bone growth.
- unhealed skin lesions in the lower extremities.
- thromboembolic diseases, cardiovascular instability.
- aggressive or self-harming behaviors.
See the full eligibility criteria
- Children with a diagnosis of bilateral spastic CP attributed to complications of prematurity, intracranial hemorrhage and periventricular leukmalacia according to the definition of Bax.
- Children aged 4 to 12 years old without Botulinum toxin treatment within 6 months, and without surgeries (such as selective dorsal rhizotomy) within 12 months before the onset of the training.
- people will be able to remain seated without help for ≥10s.
- GMFCS levels will be I to IV.
- Children must be able to signal pain, fear or discomfort reliably.
- Children with mild scoliosis (Cobb angle \< 20 °).
- Children with CP who have no prior hippotherapy experiences within 6 months.
- severe lower extremity contractures, fractures, osseous instabilities, osteoporosis.
- severe disproportional bone growth.
- unhealed skin lesions in the lower extremities.
- thromboembolic diseases, cardiovascular instability.
- aggressive or self-harming behaviors.
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.